Ajanta Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ajanta Pharma Ltd (AJPH)
Track today's live Ajanta Pharma Ltd (AJPH) share price, performance and key data on this page with our current NSE:AJPH stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Ajanta Pharma Ltd share price on the NSE exchange. Use the dropdown to switch exchange for the AJPH share price, head to our technical summary section, which provides analysis on Ajanta Pharma Ltd share price buy/sell indicators using real-time data (or discuss the Ajanta Pharma Ltd (AJPH) stock price today with other investors in the Ajanta Pharma Ltd NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:AJPH share price (ISIN: INE031B01049) to enhance your trading decisions with our free investment tools and resources.
What Is the Ajanta Pharma Ltd Share Price Today?
The Ajanta Pharma Ltd share price today is 3,525.10.
What Is the Stock Symbol for Ajanta Pharma Ltd
The stock symbol (or 'ticker') for Ajanta Pharma Ltd is "AJPH."
What Stock Exchange Does Ajanta Pharma Ltd Trade On?
Ajanta Pharma Ltd is listed and trades on the NSE stock exchange.
Is Ajanta Pharma Ltd a Good Stock to Buy?
Determining whether Ajanta Pharma Ltd (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:AJPH share price (ISIN: INE031B01049) to enhance your trading decisions with our free investment tools and resources.
What Is the Ajanta Pharma Ltd Share Price Today?
The Ajanta Pharma Ltd share price today is 3,525.10.
What Is the Stock Symbol for Ajanta Pharma Ltd
The stock symbol (or 'ticker') for Ajanta Pharma Ltd is "AJPH."
What Stock Exchange Does Ajanta Pharma Ltd Trade On?
Ajanta Pharma Ltd is listed and trades on the NSE stock exchange.
Is Ajanta Pharma Ltd a Good Stock to Buy?
Determining whether Ajanta Pharma Ltd (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
3,525.10
+11.20(+0.32%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,504.40
3,550.00
52 wk Range
2,329.90
3,598.80
AJPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,504.403,550.00
52 wk Range
2,329.903,598.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.73%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.73%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
AJPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
3,729.57
Upside
+5.80%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Ajanta Pharma Ltd receives Investment Bank Analyst Rating Update- Investing.com
Pro
Ajanta Pharma Ltd receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Ajanta Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Ajanta Pharma Ltd receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
11 Buy
2 Hold
1 Sell
Ratings:
14 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 3,729.57
(+5.80% Upside)
Ajanta Pharma Ltd Earnings Call Summary for Q1/2027
- Ajanta Pharma Q1 FY2027 revenue rose 25% YoY to INR 1,626 crores; PAT jumped 31% to INR 334 crores with 80% gross margin and 28% EBITDA margin.
- India business grew 24%, Africa 30%, U.S. 57%; Asia fell 16% due to Middle East geopolitical supply chain disruptions expected to normalize in Q2.
- Management maintained full-year high-teens revenue growth guidance; expects gross margin ~78% and EBITDA margin ~27% for FY2027, both ±100 bps.
- Company plans 5-7 U.S. generic filings in FY2027 with most launches in December quarter; INR 400 crores capex includes INR 300 crores for Pithampur expansion.
- Shares rose 1.34% to $3,442, near 52-week high of $3,598.8; declared INR 32 interim dividend per share, continuing 20-year dividend payment streak.
Last Updated: 30/07/2026, 12:54
Read Full TranscriptEarnings
Latest Release
30/07/2026
EPS / Forecast
26.72 / 23.93
Revenue / Forecast
16.26B / 15.1B
Compare AJPH to Peers and Sector
Metrics to compare | AJPH | Peers Peers - average of corresponding metrics from companies closely matching AJPH: MANKIND, CIPLA, EMCURE, TORNTPHARM, LUPIN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAJPHPeersSector |
|---|---|---|---|---|
P/E Ratio | 38.7x | 33.0x | −0.4x | |
PEG Ratio | 1.76 | 1.08 | 0.00 | |
Price/Book | 9.7x | 5.4x | 2.6x | |
Price / LTM Sales | 7.6x | 6.6x | 3.0x | |
Upside (Analyst Target) | 8.0% | 5.0% | 54.3% | |
Fair Value Upside | Unlock | 2.3% | 8.4% | Unlock |
Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, eye drops, dry powder suspension, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, gynaecology, nephrology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Ajanta Pharma Ltd (NSE: AJPH) Share Price Today?
The Ajanta Pharma Ltd stock price today is 3,525.10 INR.
What Stock Exchange Does Ajanta Pharma Ltd (AJPH) Trade On?
Ajanta Pharma Ltd is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Ajanta Pharma Ltd?
The stock symbol (also called a 'ticker') for Ajanta Pharma Ltd is "AJPH."
Does Ajanta Pharma Ltd Pay Dividends? What’s The Current AJPH Dividend Yield?
Yes, AJPH Pays Dividends to its Shareholders. The current Ajanta Pharma Ltd dividend yield is 1.73%.
What Is the Current Ajanta Pharma Ltd Market Capitalisation?
As of today, Ajanta Pharma Ltd (NSE: AJPH) market cap is 440.14B INR.
What Is Ajanta Pharma Ltd's (AJPH) Earnings Per Share (TTM)?
The Ajanta Pharma Ltd EPS is currently 90.80 (Trailing Twelve Months).
When Is the Next Ajanta Pharma Ltd Earnings Date?
Ajanta Pharma Ltd's next earnings report will be released on 04/11/2026.
Is AJPH a Buy or Sell From a Technical Analyst Perspective?
Based on today's Ajanta Pharma Ltd moving averages and other technical indicators, the daily buy/sell signal for AJPH stock is Strong Buy.
How Many Times Has Ajanta Pharma Ltd Stock Split?
Ajanta Pharma Ltd has split 4 times. (See the AJPH stock split history page for full effective split date and price information.)
How Many Employees Does Ajanta Pharma Ltd Have?
Ajanta Pharma Ltd has 9628 employees, based on their latest Companies House report.
What is the current trading status of Ajanta Pharma Ltd (NSE: AJPH)?
As of 04/08/2026, Ajanta Pharma Ltd (AJPH) is trading at a share price of 3,525.10 INR, with a previous close of 3,513.90 INR. The stock has fluctuated within a day range of 3,504.40 INR to 3,550.00 INR, while its 52-week range spans from 2,329.90 INR to 3,598.80 INR.
What Is Ajanta Pharma Ltd (AJPH) Price Target According to Analysts?
The average 12-month price target for Ajanta Pharma Ltd is 3,729.57 INR, with a high estimate of 4131 INR and a low estimate of 3109 INR. 11 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +5.80% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.